Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. Hosting Providers

We began analyzing https://link.springer.com/article/10.1023/B:JOMG.0000010028.48159.84, but it redirected us to https://link.springer.com/article/10.1023/B:JOMG.0000010028.48159.84. The analysis below is for the second page.

Title[redir]:
Expression Profiling of Human Breast Cancers and Gene Regulation by Progesterone Receptors | Journal of Mammary Gland Biology and Neoplasia
Description:
Even the first expression profiling studies of breast cancers have generated new insights. They suggest for example, that information about tumor aggressiveness, prognosis, metastatic potential, or treatment outcome is encoded in, and can be deduced from, the primary tumor. On the other hand no clinical genomic array data have yet been published that deal with hormonal aspects of breast tumorigenesis, tumor progression, or therapeutics. Rather, studies have focused on experimental model systems. We review below the currently published data on array profiling in clinical breast cancer, then describe our studies in breast cancer cell lines and xenograft models dealing with progesterone receptors (PRs) and the role of progesterone. We demonstrate that the two PR isoforms, PR-A and PR-B, have mostly nonoverlapping molecular signatures when liganded by progesterone, with PR-B the more active form. Additionally, we document the surprising finding that unliganded PRs can regulate gene transcription, with PR-A the more active form. In ovariectomized mice supplemented with estradiol but lacking measurable progesterone, PR-B-expressing tumors grow to twice the size of PR-A-expressing ones. We conclude that in breast cancers, PRs are more than simple markers of estrogen receptor function. Rather, presence of PRs and the ratio of the two isoforms directly influence tumor phenotype, even in the absence of ligand.

Matching Content Categories {πŸ“š}

  • Education
  • Science
  • Health & Fitness

Content Management System {πŸ“}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {πŸ’Έ}

We're unsure how the site profits.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Doi.org might be making money, but it's not detectable how they're doing it.

Keywords {πŸ”}

google, scholar, cancer, breast, expression, progesterone, gene, human, receptor, receptors, analysis, profiling, biol, natl, res, mammary, horwitz, cells, article, van, mol, tumor, usa, molecular, proc, acad, sci, chem, gland, cell, genes, endocrinol, cancers, regulation, sartorius, estrogen, access, function, data, jacobsen, clinical, isoforms, hormone, patterns, dna, nature, genet, factor, privacy, cookies,

Topics {βœ’οΈ}

ligand-independent gene regulation pr-b-expressing tumors grow month download article/chapter high-density oligonucleotide arrays unique n-terminal segment ecdysone-inducible gene expression light-generated oligonucleotide arrays high-sensitivity array analysis endogenous progestin-sensitive endpoints n-terminal inhibitory function progestin-induced growth inhibition mouse mammary gland microarray-based expression profiling human endometrial glands regulate gene transcription related subjects human progesterone receptors progesterone receptor isoforms estrogen-progestin replacement therapy promoter-specific repressor differential gene regulation gene expression profiling privacy choices/manage cookies full article pdf gene-expression profiles gene expression profiles health initiative investigators epithelial-stromal interactions human progesterone receptor gene expression patterns gene expression revealed gene expression database pr-a-expressing transgenic mice carrying tissue factor expression human breast tumours mammary gland development breast cancer cells human breast cancer mammary gland biology gene expression monitoring progesterone receptor levels limiting factor mediates primary solid tumors human malignancies based gene-expression signature human prostate cancer adjacent breast tumors 11 beta-hydroxysteroid dehydrogenase bcar1/p130cas protein

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Expression Profiling of Human Breast Cancers and Gene Regulation by Progesterone Receptors
         description:Even the first expression profiling studies of breast cancers have generated new insights. They suggest for example, that information about tumor aggressiveness, prognosis, metastatic potential, or treatment outcome is encoded in, and can be deduced from, the primary tumor. On the other hand no clinical genomic array data have yet been published that deal with hormonal aspects of breast tumorigenesis, tumor progression, or therapeutics. Rather, studies have focused on experimental model systems. We review below the currently published data on array profiling in clinical breast cancer, then describe our studies in breast cancer cell lines and xenograft models dealing with progesterone receptors (PRs) and the role of progesterone. We demonstrate that the two PR isoforms, PR-A and PR-B, have mostly nonoverlapping molecular signatures when liganded by progesterone, with PR-B the more active form. Additionally, we document the surprising finding that unliganded PRs can regulate gene transcription, with PR-A the more active form. In ovariectomized mice supplemented with estradiol but lacking measurable progesterone, PR-B-expressing tumors grow to twice the size of PR-A-expressing ones. We conclude that in breast cancers, PRs are more than simple markers of estrogen receptor function. Rather, presence of PRs and the ratio of the two isoforms directly influence tumor phenotype, even in the absence of ligand.
         datePublished:
         dateModified:
         pageStart:257
         pageEnd:268
         sameAs:https://doi.org/10.1023/B:JOMG.0000010028.48159.84
         keywords:
            human breast cancer
            gene arrays
            progesterone receptors
            PR isoforms
            ligand-independent regulation
            Oncology
            Cancer Research
         image:
         isPartOf:
            name:Journal of Mammary Gland Biology and Neoplasia
            issn:
               1573-7039
               1083-3021
            volumeNumber:8
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Kluwer Academic Publishers-Plenum Publishers
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Britta M. Jacobsen
               affiliation:
                     name:University of Colorado School of Medicine
                     address:
                        name:Department of Medicine, Division of Endocrinology, University of Colorado School of Medicine, Denver
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Jennifer K. Richer
               affiliation:
                     name:University of Colorado School of Medicine
                     address:
                        name:Department of Medicine, Division of Endocrinology, University of Colorado School of Medicine, Denver
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Carol A. Sartorius
               affiliation:
                     name:University of Colorado School of Medicine
                     address:
                        name:Department of Medicine, Division of Endocrinology, University of Colorado School of Medicine, Denver
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kathryn B. Horwitz
               affiliation:
                     name:University of Colorado School of Medicine
                     address:
                        name:Department of Medicine, Division of Endocrinology, University of Colorado School of Medicine, Denver
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Expression Profiling of Human Breast Cancers and Gene Regulation by Progesterone Receptors
      description:Even the first expression profiling studies of breast cancers have generated new insights. They suggest for example, that information about tumor aggressiveness, prognosis, metastatic potential, or treatment outcome is encoded in, and can be deduced from, the primary tumor. On the other hand no clinical genomic array data have yet been published that deal with hormonal aspects of breast tumorigenesis, tumor progression, or therapeutics. Rather, studies have focused on experimental model systems. We review below the currently published data on array profiling in clinical breast cancer, then describe our studies in breast cancer cell lines and xenograft models dealing with progesterone receptors (PRs) and the role of progesterone. We demonstrate that the two PR isoforms, PR-A and PR-B, have mostly nonoverlapping molecular signatures when liganded by progesterone, with PR-B the more active form. Additionally, we document the surprising finding that unliganded PRs can regulate gene transcription, with PR-A the more active form. In ovariectomized mice supplemented with estradiol but lacking measurable progesterone, PR-B-expressing tumors grow to twice the size of PR-A-expressing ones. We conclude that in breast cancers, PRs are more than simple markers of estrogen receptor function. Rather, presence of PRs and the ratio of the two isoforms directly influence tumor phenotype, even in the absence of ligand.
      datePublished:
      dateModified:
      pageStart:257
      pageEnd:268
      sameAs:https://doi.org/10.1023/B:JOMG.0000010028.48159.84
      keywords:
         human breast cancer
         gene arrays
         progesterone receptors
         PR isoforms
         ligand-independent regulation
         Oncology
         Cancer Research
      image:
      isPartOf:
         name:Journal of Mammary Gland Biology and Neoplasia
         issn:
            1573-7039
            1083-3021
         volumeNumber:8
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Kluwer Academic Publishers-Plenum Publishers
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Britta M. Jacobsen
            affiliation:
                  name:University of Colorado School of Medicine
                  address:
                     name:Department of Medicine, Division of Endocrinology, University of Colorado School of Medicine, Denver
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Jennifer K. Richer
            affiliation:
                  name:University of Colorado School of Medicine
                  address:
                     name:Department of Medicine, Division of Endocrinology, University of Colorado School of Medicine, Denver
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Carol A. Sartorius
            affiliation:
                  name:University of Colorado School of Medicine
                  address:
                     name:Department of Medicine, Division of Endocrinology, University of Colorado School of Medicine, Denver
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kathryn B. Horwitz
            affiliation:
                  name:University of Colorado School of Medicine
                  address:
                     name:Department of Medicine, Division of Endocrinology, University of Colorado School of Medicine, Denver
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Journal of Mammary Gland Biology and Neoplasia
      issn:
         1573-7039
         1083-3021
      volumeNumber:8
Organization:
      name:Kluwer Academic Publishers-Plenum Publishers
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Colorado School of Medicine
      address:
         name:Department of Medicine, Division of Endocrinology, University of Colorado School of Medicine, Denver
         type:PostalAddress
      name:University of Colorado School of Medicine
      address:
         name:Department of Medicine, Division of Endocrinology, University of Colorado School of Medicine, Denver
         type:PostalAddress
      name:University of Colorado School of Medicine
      address:
         name:Department of Medicine, Division of Endocrinology, University of Colorado School of Medicine, Denver
         type:PostalAddress
      name:University of Colorado School of Medicine
      address:
         name:Department of Medicine, Division of Endocrinology, University of Colorado School of Medicine, Denver
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Britta M. Jacobsen
      affiliation:
            name:University of Colorado School of Medicine
            address:
               name:Department of Medicine, Division of Endocrinology, University of Colorado School of Medicine, Denver
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Jennifer K. Richer
      affiliation:
            name:University of Colorado School of Medicine
            address:
               name:Department of Medicine, Division of Endocrinology, University of Colorado School of Medicine, Denver
               type:PostalAddress
            type:Organization
      name:Carol A. Sartorius
      affiliation:
            name:University of Colorado School of Medicine
            address:
               name:Department of Medicine, Division of Endocrinology, University of Colorado School of Medicine, Denver
               type:PostalAddress
            type:Organization
      name:Kathryn B. Horwitz
      affiliation:
            name:University of Colorado School of Medicine
            address:
               name:Department of Medicine, Division of Endocrinology, University of Colorado School of Medicine, Denver
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Medicine, Division of Endocrinology, University of Colorado School of Medicine, Denver
      name:Department of Medicine, Division of Endocrinology, University of Colorado School of Medicine, Denver
      name:Department of Medicine, Division of Endocrinology, University of Colorado School of Medicine, Denver
      name:Department of Medicine, Division of Endocrinology, University of Colorado School of Medicine, Denver
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {πŸ”—}(164)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

Emails and Hosting {βœ‰οΈ}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com
4.53s.